Anti-HCV prevalence in the general population of lithuania

Medical Science Monitor

Volumn 18, Issue 3, 2012, Pages

  Liakin, Valentina ^a   Valantinas, Jonas ^a  

^a VILNIUS UNIVERSITY   (Lithuania)

Author keywords

Anti HCV antibodies; Hepatitis C virus; Infection; Spread

Indexed keywords

HEPATITIS C ANTIBODY;

ADULT; AGED; ANTIBODY TITER; ARTICLE; BLOOD ANALYSIS; BLOOD TRANSFUSION; CAPILLARY BLOOD; CHEMOLUMINESCENCE; CONTROLLED STUDY; FEMALE; HEPATITIS C; HUMAN; IMMUNOAFFINITY CHROMATOGRAPHY; IMMUNOASSAY; INFECTION RATE; INFECTION RISK; INJURY; INTRAVENOUS DRUG ABUSE; LENGTH OF STAY; LITHUANIA; MAJOR CLINICAL STUDY; MALE; POPULATION RISK; RISK ASSESSMENT; TATTOOING; TOOTH EXTRACTION; VENOUS BLOOD; VIRUS TRANSMISSION;

EID: 84857850684     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/msm.882511     Document Type: Article

References (66)

1. Suarez A, Rodriguez M, Riestra S et al: The prevalence of anti-HCV pos-itivity among blood donors in Asturias. A clinical-epidemiologic study. Med Clin (Barc), 1994; 103: 606-610
2. Brind AM, Codd AA, Cohen BJ et al: Low prevalence of antibody to hepatitis C virus in north east England. J Med Virol, 1990; 32: 243-248
3. Hetland G, Skaug K, Larsen J et al: Prevalence of anti-HCV in Norwegian blood donors with anti-HBc or increased ALT levels. Transfusion, 1990; 30: 776-779
4. Wantzin PS, Krogsgaard K, Dickmeiss E: Screening of Danish blood donors for hepatitis C virus antibodies. Ugeskr Laeger, 1990; 152: 2846-2848
5. Sirchia G, Almini D, Bellobuono A et al: Prevalence of hepatitis C virus antibodies in Italian blood donors. The Italian Cooperative Group. Vox Sang, 1990; 59: 26-29
6. Krusius T: [Risk of hepatitis after blood transfusion in Finland]. Duodecim, 1990; 106: 1412
7. Ayob Y, Davidson JI, Baxter A et al: Risk of hepatitis C in patients who received blood from donors subsequently shown to be carriers of hepatitis C virus. Transfus Med, 1994; 4: 269-272
8. Lindholm A: Epidemiology of viral infections in the Swedish blood-donor population. Blood Coagul Fibrinolysis, 1994; 5(Suppl.3): S13-S17
9. Crawford RJ, Gillon J, Yap PL et al: Prevalence and epidemiological characteristics of hepatitis C in Scottish blood donors. Transfus Med, 1994; 4: 121-124
10. Goodrick MJ, Gray SF, Rouse AM et al: Hepatitis C (HCV)-positive blood donors in south-west England: a case control study. Transfus Med, 1994; 4: 113-119
11. Wolff C, Kleesiek K, Petersen N, Beyer J: Hepatitis C viremia in German blood donors: serum alanine aminotransferase is not a valid marker for screening. Transfusion, 1994; 34: 361-362
12. Nordoy I, Schrumpf E, Elgjo K et al: Liver disease in anti-hepatitis C virus-positive Norwegian blood donors. Scand J Gastroenterol, 1994; 29: 77-81
13. Aguelles O, Janot C: Epidemiology of anti-HCV antibodies in France. Viral Hepatitis Study Group of the French Blood Transfusion Society. Arch Virol Suppl, 1992; 4: 249-252
14. Wiegand J, Luz B, Mengelkamp AK et al: Autologous blood donor screening indicated a lower prevalence of viral hepatitis in East vs West Germany: epidemiological beneft from established health resources. J Viral Hepat, 2009; 16: 743-748
15. La TG, De VE, Langiano E et al: Epidemiology of hepatitis C virus antibodies in blood donors from the province of Latina, Italy. Eur J Epidemiol, 2003; 18: 691-694
16. Zervou EK, Boumba DS, Liaskos C et al: Low prevalence of HCV, HIV, and HTLV-I/II infection markers in northwestern Greece: results of a 3-year prospective donor study (1995-1997). Eur J Intern Med, 2003; 14: 39-44
17. Klofera M, Chalupa P, Jezek P: Hepatitis C antibodies (anti-HCV) in blood donors at the transfusion department in Brno. Cas Lek Cesk, 1994; 133: 459-462
18. Esteban JI, Sauleda S, Quer J: The changing epidemiology of hepatitis C virus infection in Europe. J Hepatol, 2008; 48: 148-162
19. Naoumov NV: Hepatitis C virus infection in Eastern Europe. J Hepatol, 1999; 31(Suppl.1): 84-87
20. Nemecek V, Strunecky O: Genotypic heterogeneity of hepatitis C virus (HCV) from blood donors in the Czech Republic. Epidemiol Mikrobiol Imunol, 2009; 58: 63-72
21. Olinger CM, Lazouskaya NV, Eremin VF, Muller CP: Multiple genotypes and subtypes of hepatitis B and C viruses in Belarus: similarities with Russia and western European infuences. Clin Microbiol Infect, 2008; 14: 575-581
22. Seyfried H, Brojer E, Grabarczyk P et al: Prevalence of hepatitis C virus markers in Polish blood donors in 1994-2003. Przegl Epidemiol, 2005; 59: 807-814
23. Ambrozaitis A, Zagminas K, Balciuniene L, Widell A: Hepatitis C in Lithuania: incidence, prevalence, risk factors and viral genotypes. Clin Diagn Virol, 1995; 4: 273-284
24. Ambrozaitis A, Balciuniene L, Widell A: Hepatitis C virus genotype distribution in Lithuanian frst time blood donors. Acta Med Lituanica, 1994; 4: 21-24
25. Moher D, Schulz K, Altman D: The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet, 2001; 357: 1191-1194
26. von Elm E, Altman D, Egger M et al: The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiology, 2008; 61: 344-349
27. Vandenbroucke JP, von Elm E, Altman DG et al: Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Epidemiology, 2007; 18: 805-835
28. Daniel W: Biostatistics: A Foundation for Analysis in the Health Sciences, 1999
29. Handler A, Rosenberg D, Kennelly J, Monahan C: Analytic Methods in Maternal and Child Health, 1998
30. Chlabicz S, Bonifatiuk I, Radziwon P: Prevalence of hepatitis C virus antibodies among blood donors in north-eastern Poland. Hepatol Res, 2005; 33: 206-210
31. Kalibatas V: [The results of nucleic acid testing for viruses in individual donor test and its importance for the safety of blood]. Medicina (Kaunas), 2008; 44: 791-798
32. Kalibatas V: Payment for whole blood donations in Lithuania: the risk for infectious disease markers. Vox Sang, 2008; 94: 209-215
33. Liakina V, Speiciene D, Irnius A, Valantinas J: Changes in hepatitis C virus infection routes and genotype distribution in a Lithuanian cohort with chronic hepatitis C. Med Sci Monit, 2009; 15(4): PH17-PH23
34. Stikleryte A, Griskeviciene J, Magnius LO et al: Characterization of HCV strains in an oncohematological pediatric department reveals little horizontal transmission but multiple introductions by un-screened blood products in the past. J Med Virol, 2006; 78: 1411-1422
35. Tallo T, Lappalainen M, Tefanova V, Priimagi I: Distribution of hepatitis C virus genotypes in patients with chronic hepatitis C in northern Estonia. Acta Virol, 2000; 44: 175-178
36. Tallo T, Norder H, Tefanova V et al: Genetic characterization of hepatitis C virus strains in Estonia: fuctuations in the predominating subtype with time. J Med Virol, 2007; 79: 374-382
37. Zusinaite E, Metskula K, Salupere R: Autoantibodies and hepatitis C virus genotypes in chronic hepatitis C patients in Estonia. World J Gastroenterol, 2005; 11: 488-491
38. Rozental R, Bicans J, Shevelev V et al: Kidney transplantation from hepatitis C virus positive donors. Transplant Proc, 2002; 34: 2581
39. Dumpis U, Kovalova Z, Jansons J et al: An outbreak of HBV and HCV infection in a paediatric oncology ward: epidemiological investigations and prevention of further spread. J Med Virol, 2003; 69: 331-338
40. Lvov DK, Samokhvalov EI, Tsuda F et al: Prevalence of hepatitis C virus and distribution of its genotypes in Northern Eurasia. Arch Virol, 1996; 141: 1613-1622
41. Tretskaia TA, Shakhgil'dian IV, Iashina TL et al: The incidence of detecting hepatitis C viral antibodies in different age groups of the population in northeastern Ukraine. Vopr Virusol, 1993; 38: 137-138
42. Karnite A, Uuskula A, Raag M et al: Prevalence of hepatitis C infection (HCV) and related factors among infecting drug users (IDUs) in Estonia, Latvia and Lithuania. XVIII international AIDS conference, Vienna, July 18-23, 2010 Abstract book, 2010; 2: 180
43. Esteban JI, Gonzalez A, Hernandez JM et al: Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis. N Engl J Med, 1990; 323: 1107-12
44. Mohebati A, Davis JM, Fry DE: Current risks of occupational blood-borne viral infection. Surg Infect (Larchmt), 2010; 11: 325-331
45. de Mattos Camargo GS, Teixeira R, de Oliveira GC, do Carmo MA: Detection of HCV RNA in saliva does not correlate with salivary fow or xerostomia in patients with chronic hepatitis C. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2010; 109: 851-856
46. Ashkenazi M, Fisher N, Levin L, Littner MM: Seroepidemiology of hepatitis C antibodies among dentists and their self-reported use of infection control measures. Community Dent Health, 2009; 26: 99-103
47. Nagao Y, Matsuoka H, Kawaguchi T et al: HBV and HCV infection in Japanese dental care workers. Int J Mol Med, 2008; 21: 791-799
48. Eirea M, Dios PD, Hermida M et al: Detection of HCV-RNA in saliva of HIV-HCV coinfected patients. AIDS Res Hum Retroviruses, 2005; 21: 1011-1015
49. Ferreiro MC, Dios PD, Scully C: Transmission of hepatitis C virus by saliva? Oral Dis, 2005; 11: 230-235
50. Ransy DG, Akouamba BS, Samson J et al: [Maternal immunity and mother-to-child transmission of HCV and HIV-1: challenges and recent advances]. Med Sci (Paris), 2007; 23: 991-996
51. McIntyre PG, Tosh K, McGuire W: Caesarean section versus vaginal delivery for preventing mother to infant hepatitis C virus transmission. Cochrane Database Syst Rev, 2006; CD005546
52. Goldberg D, Anderson E: Hepatitis C: who is at risk and how do we identify them? J Viral Hepat, 2004; 11(Suppl.1): 12-18
53. Steininger C, Kundi M, Jatzko G et al: Increased risk of mother-to-infant transmission of hepatitis C virus by intrapartum infantile exposure to maternal blood. J Infect Dis, 2003; 187: 345-351
54. Lima MP, Pedro RJ, Rocha MD: Prevalence and risk factors for hepatitis C virus (HCV) infection among pregnant Brazilian women. Int J Gynaecol Obstet, 2000; 70: 319-26
55. Ak O, Batirel A, Ozer S, Colakoglu S: Nosocomial infections and risk factors in the intensive care unit of a teaching and research hospital: a prospective cohort study. Med Sci Monit, 2011; 17(5): H29-H34
56. Erhabor O, Ejele OA, Nwauche CA: Epidemiology and management of occupational exposure to blood borne viral infections in a resource poor setting: the case for availability of post exposure prophylaxis. Niger J Clin Pract, 2007; 10: 100-104
57. Otedo AE, Mc'Ligeyo SO, Okoth FA, Kayima JK: Seroprevalence of hepatitis B and C in maintenance dialysis in a public hospital in a developing country. S Afr Med J, 2003; 93: 380-384
58. Pena MJ, Molina L, Hortal L et al: Epidemiologic study of infection by hepatitis C virus in a hemodialysis unit. Enferm Infecc Microbiol Clin, 2000; 18: 496-499
59. Catalani C, Biggeri A, Gottard A et al: Prevalence of HCV infection among health care workers in a hospital in central Italy. Eur J Epidemiol, 2004; 19: 73-77
60. Baghaei A, Sarrafzadegan N, Rabiei K et al: How effective are strategies for non-communicable disease prevention and control in a high risk population in a developing country? Isfahan Healthy Heart Programme. Archives of Medical Science, 2011; 6: 24-31
61. Ho MS, Yang CS, Chen PJ, Mau YC: Intrafamilial transmission of hepatitis C virus. J Clin Microbiol, 1994; 32: 2824-2826
62. Vegnente A, Iorio R, Saviano A et al: Lack of intrafamilial transmission of hepatitis C virus in family members of children with chronic hepatitis c infection. Pediatr Infect Dis J, 1994; 13: 886-889
63. Kojima T, Yamanaka T: Transmission routes of hepatitis C virus: analysis of anti-HCV-positive pregnant women and their family members. Nippon Sanka Fujinka Gakkai Zasshi, 1994; 46: 573-580
64. Chang TT, Liou TC, Young KC et al: Intrafamilial transmission of hepatitis C virus: the important role of inapparent transmission. J Med Virol, 1994; 42: 91-96
65. Gyarmathy VA, Neaigus A, Li N et al: Infection disclosure in the injecting dyads of Hungarian and Lithuanian injecting drug users who self-reported being infected with hepatitis C virus or human immunodef-ciency virus. Scand J Infect Dis, 2011; 43: 32-42
66. Gyarmathy VA, Neaigus A, Li N et al: Liquid drugs and high dead space syringes may keep HIV and HCV prevalence high - a comparison of Hungary and Lithuania. Eur Addict Res, 2010; 16: 220-228